Mr. Antal Rohit Desai - 26 Sep 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
28 Sep 2023, 16:32:06 UTC
Prior SEC filing
16 Jun 2023
Next SEC filing
07 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Antal Rohit Desai

Key filing fact

Mr. Antal Rohit Desai filed Form 4 for REATA PHARMACEUTICALS INC on 28 Sep 2023.

Key facts

  • This page summarizes Mr. Antal Rohit Desai's Form 4 filing for REATA PHARMACEUTICALS INC.
  • 24 reported transactions and 7 derivative rows are listed below.
  • Accepted by SEC: 28 Sep 2023, 16:32.

Change

  • Previous filing in this sequence was filed on 16 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-31,467
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By The 2:22 DNA Trust
Footnotes
F1, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-113
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By CPMG, Inc.
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-116,512
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Nighthawk Partners, LP
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-282,246
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Willet Fund, LP
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-137,962
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Killdeer Fund, LP
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-5,464
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Elepaio Partners, LP
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-44,200
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Barred Owl Partners, LP
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-34,897
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Managed Account for Trustees of the University of Pennsylvania
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-442,560
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Gallopavo, LP
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-748,253
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Roadrunner Fund, LP
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-431,155
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Yellow Warbler, LP
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-109,415
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Mallard Fund, LP
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-37,909
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Crested Crane, LP
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-334,740
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Sandpiper Fund, LP
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-160,265
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Kestrel Fund, LP(
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-11,076
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By CD Fund, LP
Footnotes
F2, F3, F4
RETA transaction

Class A common stock

Disposed to Issuer

Transaction value
Shares
-134
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Redbird Life Sciences Partners, LP
Footnotes
F2, F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RETA transaction Derivative

Class B common stock

Disposed to Issuer

Transaction value
Shares
-1,251
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By CPMG, Inc.
Underlying class
Class A common stock
Underlying amount
1,251
Exercise price
Footnotes
F2, F3, F4, F5
RETA transaction Derivative

Class B common stock

Disposed to Issuer

Transaction value
Shares
-150,186
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Mallard Fund, LP
Underlying class
Class A common stock
Underlying amount
150,186
Exercise price
Footnotes
F2, F3, F4, F5
RETA transaction Derivative

Class B common stock

Disposed to Issuer

Transaction value
Shares
-307,776
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Kestrel Fund, LP
Underlying class
Class A common stock
Underlying amount
307,776
Exercise price
Footnotes
F2, F3, F4, F5
RETA transaction Derivative

Class B common stock

Disposed to Issuer

Transaction value
Shares
-123,279
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By CD Fund, LP
Underlying class
Class A common stock
Underlying amount
123,279
Exercise price
Footnotes
F2, F3, F4, F5
RETA transaction Derivative

Class B common stock

Disposed to Issuer

Transaction value
Shares
-1,490
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Redbird Life Sciences Partners, LP
Underlying class
Class A common stock
Underlying amount
1,490
Exercise price
Footnotes
F2, F3, F4, F5
RETA transaction Derivative

Class B common stock

Disposed to Issuer

Transaction value
Shares
-114,946
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Willet Fund, LP
Underlying class
Class A common stock
Underlying amount
114,946
Exercise price
Footnotes
F2, F3, F4, F5
RETA transaction Derivative

Class B common stock

Disposed to Issuer

Transaction value
Shares
-993,929
Change %
-100%
Price
Shares after
0
Date
26 Sep 2023
Ownership
By Yellow Warbler, LP
Underlying class
Class A common stock
Underlying amount
993,929
Exercise price
Footnotes
F2, F3, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Mr. Antal Rohit Desai is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 5 footnotes

Footnote F1

Mr. Desai and his spouse serve as co-trustees of The 2:22 DNA Trust.

Footnote F2

CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the "Funds"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4.

Footnote F3

Each of CPMG, Inc. and Mr. Desai (collectively, the "Reporting Persons") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.

Footnote F4

Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. ("Biogen") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the "Effective Time"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes.

Footnote F5

The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date.

SEC remarks

Mr. McGaughy, Jr. serves on the Issuer's Board of Directors (the "Board") as a representative of CPMG, Inc. By virtue of his representation on the Board, for purposes of Section 16 of the Exchange Act, the Reporting Persons may be deemed to be directors of the Issuer by deputization of Mr. McGaughy, Jr.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .